Modeling longitudinal daily seizure frequency data from pregabalin add-on treatment
2012 (English)In: Journal of clinical pharmacology, ISSN 0091-2700, E-ISSN 1552-4604, Vol. 52, no 6, 880-892 p.Article in journal (Refereed) Published
The purpose of this study was to describe longitudinal daily seizure count data with respect to the effects of time and pregabalin add-on therapy. Models were developed in step-wise manner: base model, time effect model, and time and drug effect (final) model, using a negative binomial distribution with Markovian features. Mean daily seizure count (λ) was estimated to be 0.385 (RSE 3.09%) and was further increased depending on the seizure count on the previous day. An overdispersion parameter (OVDP), representing extra-Poisson variation, was estimated to be 0.330 (RSE 11.7%). Inter-individual variances on λ and OVDP were 84.7% and 210%, respectively. Over time, λ tended to increase exponentially with a rate constant of 0.272 year-1 (RSE 26.8%). A mixture model was applied to classify responders/non-responders to pregabalin treatment. Within the responders, λ decreased exponentially with respect to dose with a constant of 0.00108 mg-1 (RSE 11.9%). The estimated responder rate was 66% (RSE 27.6%). Simulation-based diagnostics showed the model reasonably reproduced the characteristics of observed data. Highly variable daily seizure frequency was successfully characterized incorporating baseline characteristics, time effect, and the effect of pregabalin with classification of responders/non-responders, all of which are necessary to adequately assess the efficacy of antiepileptic drugs.
Place, publisher, year, edition, pages
2012. Vol. 52, no 6, 880-892 p.
Count data, negative binomial distribution, pregabalin, epilepsy, NONMEM 7
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-150927DOI: 10.1177/0091270011407193ISI: 000304228900010PubMedID: 21646441OAI: oai:DiVA.org:uu-150927DiVA: diva2:409331